• Öner Odabaş, Irem Gül Sancak, Yusuf Kasap, Zerrin Mahmut, Erkan Ölçücüoğlu, Sedat Taştemur, and Neslihan Zengin.
• Urology Clinic, Ankara Bilkent City Hospital, University of Health Sciences, Ankara, Turkey
• Turk J Med Sci. 2020 Aug 26; 50 (5): 1210-1216.

Background/AimThe male sling operation and artificial urinary sphincter implantation are common methods for treating urinary incontinence. However, there are some drawbacks to these methods such as infection, urethral erosion, pain, inefficiency, and the technical difficulty of the operations. Here we describe a new device we have named the Turkish Continence Device (TCD) which has advantages over these other methods. The aim of this study was perform experiments with the TCD prototype in vivo and ex vivo to determine efficiency, convenience of implantation, and negative effects.Materials And MethodsWe implanted the prototype device in male goats and sheep, compressing the posterior urethra, and then fixed it by sutures on the lateral sides of the cavernosal bodies, bilaterally. Then we recorded urodynamic findings and performed urinary imaging. Additionally we measured urethral closure pressure ex vivo.ResultsThe balloon volume for efficient urethral closure pressure using the new device was under 1 mL. It compressed the urethra towards the corpus cavernosum perfectly, because the wings of the prototype device are fixed near the tunica of the cavernosal bodies on each side.ConclusionA smaller device with smaller arms/wings would be efficient for obtaining enough pressure on the urethra. Additionally, the technique for implanting the device is very simple and would likely be learned quickly.This work is licensed under a Creative Commons Attribution 4.0 International License.

23 keywords...

hide…